NASDAQ:SPRO

Spero Therapeutics Stock Dividends

Healthcare > Biotechnology

Buy SPRO

*Your capital is at risk

$2.80

-0.0300 (-1.06%)

At Close: Jun 03, 2026

SPRO Dividends Insights

SPRO used to pay dividends quarterly. Last paid amount was $0.0150 at Oct 07, 2015. As of today, dividend yield (TTM) is 0%.

Dividend Score Premium

Avoid dividend cuts
with our Dividend Score
Start 7-Day Free Trial

Safety Rating

AI Analysis of SPRO

AI-Powered Dividend Insights

Built on AI-powered analysis of yield strength, recent news, payout trends, and 10-year dividend growth consistency.

Dividend Yield Range

The Dividend Yield Range is the range of values in which a stock’s dividend yield has fluctuated within a specified period, often a year. It represents the variation between the highest and lowest dividend yields observed during that time frame.

AI Analysis of SPRO

AI-Powered Market Insights

New!

Dividend Analysis

Key Stats

Dividend Yield (TTM)	0%
Frequency	Quarterly
1Y Growth	0%
Payout Ratio	0
Amount Per Share	$0.0150
Spero Therapeutics Inc. has not yet announced its next dividend date. Last payment date was: Oct 07, 2015.

SPRO Dividend Payout History

To ensure a understanding of SPRO's dividend performance, consider examining the historical payout ratios and how they align with the company's earnings. Fluctuations in payout amounts may reflect changes in the company's dividend policy or earnings stability.

#	Declaration Date	Ex-Date	Pay Date	Amount	Yield
1	Aug 07, 2015	Sep 16, 2015	Oct 07, 2015	$0.0150	0%
2	May 06, 2015	Jun 17, 2015	Jul 07, 2015	$0.0150	0%
3	Mar 06, 2015	Mar 18, 2015	Apr 07, 2015	$0.0150	0%
4	Nov 05, 2014	Dec 17, 2014	Jan 06, 2015	$0.0150	0%
5	Aug 11, 2014	Sep 17, 2014	Oct 07, 2014	$0.0150	0%
6	May 09, 2014	Jun 18, 2014	Jul 07, 2014	$0.0150	0%
7	Mar 06, 2014	Mar 19, 2014	Apr 07, 2014	$0.0150	0%
8	Nov 08, 2013	Dec 17, 2013	Jan 06, 2014	$0.0150	0%
9	Aug 07, 2013	Sep 17, 2013	Oct 07, 2013	$0.0150	0%
10	May 08, 2013	Jun 12, 2013	Jul 05, 2013	$0.0150	0%

Requires Login

Dividend Sustainability

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Overall, the near-term dividend outlook remains unpromising.

DSS - Sustainability score

Average (43.32%)

DSGP - Growth potential

Potential for dividend initiation, but uncertain (19.08%)

SPRO Stock Competitors

Symbol	Company Name	Market Cap	Amount Per Share	Dividend Yield (TTM)	Payout Ratio (TTM)
SPRO	Spero Therapeutics Inc.	162.124M	$0.0150	0%	-

FAQ

What factors can affect the amount of SPRO's dividend payments?

The amount of SPRO's dividends can fluctuate based on several factors, including the company's financial performance, earnings, cash flow, capital requirements, and overall market conditions. Changes in SPRO sector's trends, interest rate shifts, and the company's operational adjustments can also influence dividend decisions.

Can dividends from SPRO stock be automatically reinvested?

If SPRO offers a Dividend Reinvestment Plan (DRIP), shareholders may have the option to automatically reinvest dividends to purchase additional shares. Please check with your brokerage for the availability and details of such a plan. Here's an easy guide on how to buy SPRO stock.

How often does SPRO pay dividend?

Spero Therapeutics Inc. (SPRO) used to pay dividends quarterly. The most recent payout was on Oct 07, 2015.

How much does SPRO pays per share?

The last recorder (Sep 16, 2015) dividend per share was $0.0150.

What is SPRO dividend growth rate?

Over the last year, Spero Therapeutics Inc. has witnessed growth rate of 0% . Looking back over the past 3 years, this growth rate has been 0%. Furthermore, examining the past 5 years, Spero Therapeutics Inc. has maintained an average Dividends Per Share Growth Rate of 0%.

ABOUT SPERO THERAPEUTICS INC.

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, a direct actin...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by